Medical Care
Global CD115 Antibody Market Research Report 2025
- May 12, 25
- ID: 236064
- Pages: 99
- Figures: 101
- Views: 8
The global market for CD115 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
CD115 (CSF-1R) is expressed on monocytes/macrophages, peritoneal exudate cells, plasmacytoid cells, dendritic cells, and osteoclasts. Background. CD115 antibody, clone AFS98, recognizes CD115, also known as mouse colony-stimulating factor 1 receptor (CSF-1R and macrophage colony-stimulating factor receptor (M-CSFR).
North American market for CD115 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CD115 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of CD115 Antibody include Thermo Fisher Scientific, BosterBio, Bioss, BD Biosciences, RayBiotech, BioLegend, LifeSpan BioSciences, Bio-Rad, Antigenix America, Leinco Technologies, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CD115 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD115 Antibody.
The CD115 Antibody market size, estimations, and forecasts are provided in terms of sales volume (ml) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD115 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD115 Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Thermo Fisher Scientific
BosterBio
Bioss
BD Biosciences
RayBiotech
BioLegend
LifeSpan BioSciences
Bio-Rad
Antigenix America
Leinco Technologies
Novus Biologicals
Tonbo Biosciences
ichorbio
R&D Systems
AffinityImmuno
Proteintech Group
GeneTex
Biobyt
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of CD115 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of CD115 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
CD115 (CSF-1R) is expressed on monocytes/macrophages, peritoneal exudate cells, plasmacytoid cells, dendritic cells, and osteoclasts. Background. CD115 antibody, clone AFS98, recognizes CD115, also known as mouse colony-stimulating factor 1 receptor (CSF-1R and macrophage colony-stimulating factor receptor (M-CSFR).
North American market for CD115 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CD115 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of CD115 Antibody include Thermo Fisher Scientific, BosterBio, Bioss, BD Biosciences, RayBiotech, BioLegend, LifeSpan BioSciences, Bio-Rad, Antigenix America, Leinco Technologies, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CD115 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD115 Antibody.
The CD115 Antibody market size, estimations, and forecasts are provided in terms of sales volume (ml) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD115 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD115 Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Thermo Fisher Scientific
BosterBio
Bioss
BD Biosciences
RayBiotech
BioLegend
LifeSpan BioSciences
Bio-Rad
Antigenix America
Leinco Technologies
Novus Biologicals
Tonbo Biosciences
ichorbio
R&D Systems
AffinityImmuno
Proteintech Group
GeneTex
Biobyt
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of CD115 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of CD115 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 CD115 Antibody Market Overview
1.1 Product Definition
1.2 CD115 Antibody by Type
1.2.1 Global CD115 Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 CD115 Antibody by Application
1.3.1 Global CD115 Antibody Market Value by Application (2024 VS 2031)
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Global CD115 Antibody Market Size Estimates and Forecasts
1.4.1 Global CD115 Antibody Revenue 2020-2031
1.4.2 Global CD115 Antibody Sales 2020-2031
1.4.3 Global CD115 Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 CD115 Antibody Market Competition by Manufacturers
2.1 Global CD115 Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global CD115 Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global CD115 Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of CD115 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of CD115 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CD115 Antibody, Product Type & Application
2.7 Global Key Manufacturers of CD115 Antibody, Date of Enter into This Industry
2.8 Global CD115 Antibody Market Competitive Situation and Trends
2.8.1 Global CD115 Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest CD115 Antibody Players Market Share by Revenue
2.8.3 Global CD115 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global CD115 Antibody Market Scenario by Region
3.1 Global CD115 Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global CD115 Antibody Sales by Region: 2020-2031
3.2.1 Global CD115 Antibody Sales by Region: 2020-2025
3.2.2 Global CD115 Antibody Sales by Region: 2026-2031
3.3 Global CD115 Antibody Revenue by Region: 2020-2031
3.3.1 Global CD115 Antibody Revenue by Region: 2020-2025
3.3.2 Global CD115 Antibody Revenue by Region: 2026-2031
3.4 North America CD115 Antibody Market Facts & Figures by Country
3.4.1 North America CD115 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America CD115 Antibody Sales by Country (2020-2031)
3.4.3 North America CD115 Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe CD115 Antibody Market Facts & Figures by Country
3.5.1 Europe CD115 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe CD115 Antibody Sales by Country (2020-2031)
3.5.3 Europe CD115 Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CD115 Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific CD115 Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific CD115 Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific CD115 Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CD115 Antibody Market Facts & Figures by Country
3.7.1 Latin America CD115 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America CD115 Antibody Sales by Country (2020-2031)
3.7.3 Latin America CD115 Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CD115 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa CD115 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa CD115 Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa CD115 Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CD115 Antibody Sales by Type (2020-2031)
4.1.1 Global CD115 Antibody Sales by Type (2020-2025)
4.1.2 Global CD115 Antibody Sales by Type (2026-2031)
4.1.3 Global CD115 Antibody Sales Market Share by Type (2020-2031)
4.2 Global CD115 Antibody Revenue by Type (2020-2031)
4.2.1 Global CD115 Antibody Revenue by Type (2020-2025)
4.2.2 Global CD115 Antibody Revenue by Type (2026-2031)
4.2.3 Global CD115 Antibody Revenue Market Share by Type (2020-2031)
4.3 Global CD115 Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global CD115 Antibody Sales by Application (2020-2031)
5.1.1 Global CD115 Antibody Sales by Application (2020-2025)
5.1.2 Global CD115 Antibody Sales by Application (2026-2031)
5.1.3 Global CD115 Antibody Sales Market Share by Application (2020-2031)
5.2 Global CD115 Antibody Revenue by Application (2020-2031)
5.2.1 Global CD115 Antibody Revenue by Application (2020-2025)
5.2.2 Global CD115 Antibody Revenue by Application (2026-2031)
5.2.3 Global CD115 Antibody Revenue Market Share by Application (2020-2031)
5.3 Global CD115 Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Scientific CD115 Antibody Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 BosterBio
6.2.1 BosterBio Company Information
6.2.2 BosterBio Description and Business Overview
6.2.3 BosterBio CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BosterBio CD115 Antibody Product Portfolio
6.2.5 BosterBio Recent Developments/Updates
6.3 Bioss
6.3.1 Bioss Company Information
6.3.2 Bioss Description and Business Overview
6.3.3 Bioss CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bioss CD115 Antibody Product Portfolio
6.3.5 Bioss Recent Developments/Updates
6.4 BD Biosciences
6.4.1 BD Biosciences Company Information
6.4.2 BD Biosciences Description and Business Overview
6.4.3 BD Biosciences CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BD Biosciences CD115 Antibody Product Portfolio
6.4.5 BD Biosciences Recent Developments/Updates
6.5 RayBiotech
6.5.1 RayBiotech Company Information
6.5.2 RayBiotech Description and Business Overview
6.5.3 RayBiotech CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 RayBiotech CD115 Antibody Product Portfolio
6.5.5 RayBiotech Recent Developments/Updates
6.6 BioLegend
6.6.1 BioLegend Company Information
6.6.2 BioLegend Description and Business Overview
6.6.3 BioLegend CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BioLegend CD115 Antibody Product Portfolio
6.6.5 BioLegend Recent Developments/Updates
6.7 LifeSpan BioSciences
6.7.1 LifeSpan BioSciences Company Information
6.7.2 LifeSpan BioSciences Description and Business Overview
6.7.3 LifeSpan BioSciences CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 LifeSpan BioSciences CD115 Antibody Product Portfolio
6.7.5 LifeSpan BioSciences Recent Developments/Updates
6.8 Bio-Rad
6.8.1 Bio-Rad Company Information
6.8.2 Bio-Rad Description and Business Overview
6.8.3 Bio-Rad CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bio-Rad CD115 Antibody Product Portfolio
6.8.5 Bio-Rad Recent Developments/Updates
6.9 Antigenix America
6.9.1 Antigenix America Company Information
6.9.2 Antigenix America Description and Business Overview
6.9.3 Antigenix America CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Antigenix America CD115 Antibody Product Portfolio
6.9.5 Antigenix America Recent Developments/Updates
6.10 Leinco Technologies
6.10.1 Leinco Technologies Company Information
6.10.2 Leinco Technologies Description and Business Overview
6.10.3 Leinco Technologies CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Leinco Technologies CD115 Antibody Product Portfolio
6.10.5 Leinco Technologies Recent Developments/Updates
6.11 Novus Biologicals
6.11.1 Novus Biologicals Company Information
6.11.2 Novus Biologicals Description and Business Overview
6.11.3 Novus Biologicals CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Novus Biologicals CD115 Antibody Product Portfolio
6.11.5 Novus Biologicals Recent Developments/Updates
6.12 Tonbo Biosciences
6.12.1 Tonbo Biosciences Company Information
6.12.2 Tonbo Biosciences Description and Business Overview
6.12.3 Tonbo Biosciences CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Tonbo Biosciences CD115 Antibody Product Portfolio
6.12.5 Tonbo Biosciences Recent Developments/Updates
6.13 ichorbio
6.13.1 ichorbio Company Information
6.13.2 ichorbio Description and Business Overview
6.13.3 ichorbio CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 ichorbio CD115 Antibody Product Portfolio
6.13.5 ichorbio Recent Developments/Updates
6.14 R&D Systems
6.14.1 R&D Systems Company Information
6.14.2 R&D Systems Description and Business Overview
6.14.3 R&D Systems CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 R&D Systems CD115 Antibody Product Portfolio
6.14.5 R&D Systems Recent Developments/Updates
6.15 AffinityImmuno
6.15.1 AffinityImmuno Company Information
6.15.2 AffinityImmuno Description and Business Overview
6.15.3 AffinityImmuno CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.15.4 AffinityImmuno CD115 Antibody Product Portfolio
6.15.5 AffinityImmuno Recent Developments/Updates
6.16 Proteintech Group
6.16.1 Proteintech Group Company Information
6.16.2 Proteintech Group Description and Business Overview
6.16.3 Proteintech Group CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Proteintech Group CD115 Antibody Product Portfolio
6.16.5 Proteintech Group Recent Developments/Updates
6.17 GeneTex
6.17.1 GeneTex Company Information
6.17.2 GeneTex Description and Business Overview
6.17.3 GeneTex CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.17.4 GeneTex CD115 Antibody Product Portfolio
6.17.5 GeneTex Recent Developments/Updates
6.18 Biobyt
6.18.1 Biobyt Company Information
6.18.2 Biobyt Description and Business Overview
6.18.3 Biobyt CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Biobyt CD115 Antibody Product Portfolio
6.18.5 Biobyt Recent Developments/Updates
6.19 Jingjie PTM BioLab
6.19.1 Jingjie PTM BioLab Company Information
6.19.2 Jingjie PTM BioLab Description and Business Overview
6.19.3 Jingjie PTM BioLab CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Jingjie PTM BioLab CD115 Antibody Product Portfolio
6.19.5 Jingjie PTM BioLab Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CD115 Antibody Industry Chain Analysis
7.2 CD115 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CD115 Antibody Production Mode & Process Analysis
7.4 CD115 Antibody Sales and Marketing
7.4.1 CD115 Antibody Sales Channels
7.4.2 CD115 Antibody Distributors
7.5 CD115 Antibody Customer Analysis
8 CD115 Antibody Market Dynamics
8.1 CD115 Antibody Industry Trends
8.2 CD115 Antibody Market Drivers
8.3 CD115 Antibody Market Challenges
8.4 CD115 Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 CD115 Antibody by Type
1.2.1 Global CD115 Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 CD115 Antibody by Application
1.3.1 Global CD115 Antibody Market Value by Application (2024 VS 2031)
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Global CD115 Antibody Market Size Estimates and Forecasts
1.4.1 Global CD115 Antibody Revenue 2020-2031
1.4.2 Global CD115 Antibody Sales 2020-2031
1.4.3 Global CD115 Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 CD115 Antibody Market Competition by Manufacturers
2.1 Global CD115 Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global CD115 Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global CD115 Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of CD115 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of CD115 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CD115 Antibody, Product Type & Application
2.7 Global Key Manufacturers of CD115 Antibody, Date of Enter into This Industry
2.8 Global CD115 Antibody Market Competitive Situation and Trends
2.8.1 Global CD115 Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest CD115 Antibody Players Market Share by Revenue
2.8.3 Global CD115 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global CD115 Antibody Market Scenario by Region
3.1 Global CD115 Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global CD115 Antibody Sales by Region: 2020-2031
3.2.1 Global CD115 Antibody Sales by Region: 2020-2025
3.2.2 Global CD115 Antibody Sales by Region: 2026-2031
3.3 Global CD115 Antibody Revenue by Region: 2020-2031
3.3.1 Global CD115 Antibody Revenue by Region: 2020-2025
3.3.2 Global CD115 Antibody Revenue by Region: 2026-2031
3.4 North America CD115 Antibody Market Facts & Figures by Country
3.4.1 North America CD115 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America CD115 Antibody Sales by Country (2020-2031)
3.4.3 North America CD115 Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe CD115 Antibody Market Facts & Figures by Country
3.5.1 Europe CD115 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe CD115 Antibody Sales by Country (2020-2031)
3.5.3 Europe CD115 Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CD115 Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific CD115 Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific CD115 Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific CD115 Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CD115 Antibody Market Facts & Figures by Country
3.7.1 Latin America CD115 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America CD115 Antibody Sales by Country (2020-2031)
3.7.3 Latin America CD115 Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CD115 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa CD115 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa CD115 Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa CD115 Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CD115 Antibody Sales by Type (2020-2031)
4.1.1 Global CD115 Antibody Sales by Type (2020-2025)
4.1.2 Global CD115 Antibody Sales by Type (2026-2031)
4.1.3 Global CD115 Antibody Sales Market Share by Type (2020-2031)
4.2 Global CD115 Antibody Revenue by Type (2020-2031)
4.2.1 Global CD115 Antibody Revenue by Type (2020-2025)
4.2.2 Global CD115 Antibody Revenue by Type (2026-2031)
4.2.3 Global CD115 Antibody Revenue Market Share by Type (2020-2031)
4.3 Global CD115 Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global CD115 Antibody Sales by Application (2020-2031)
5.1.1 Global CD115 Antibody Sales by Application (2020-2025)
5.1.2 Global CD115 Antibody Sales by Application (2026-2031)
5.1.3 Global CD115 Antibody Sales Market Share by Application (2020-2031)
5.2 Global CD115 Antibody Revenue by Application (2020-2031)
5.2.1 Global CD115 Antibody Revenue by Application (2020-2025)
5.2.2 Global CD115 Antibody Revenue by Application (2026-2031)
5.2.3 Global CD115 Antibody Revenue Market Share by Application (2020-2031)
5.3 Global CD115 Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Scientific CD115 Antibody Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 BosterBio
6.2.1 BosterBio Company Information
6.2.2 BosterBio Description and Business Overview
6.2.3 BosterBio CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BosterBio CD115 Antibody Product Portfolio
6.2.5 BosterBio Recent Developments/Updates
6.3 Bioss
6.3.1 Bioss Company Information
6.3.2 Bioss Description and Business Overview
6.3.3 Bioss CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bioss CD115 Antibody Product Portfolio
6.3.5 Bioss Recent Developments/Updates
6.4 BD Biosciences
6.4.1 BD Biosciences Company Information
6.4.2 BD Biosciences Description and Business Overview
6.4.3 BD Biosciences CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BD Biosciences CD115 Antibody Product Portfolio
6.4.5 BD Biosciences Recent Developments/Updates
6.5 RayBiotech
6.5.1 RayBiotech Company Information
6.5.2 RayBiotech Description and Business Overview
6.5.3 RayBiotech CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 RayBiotech CD115 Antibody Product Portfolio
6.5.5 RayBiotech Recent Developments/Updates
6.6 BioLegend
6.6.1 BioLegend Company Information
6.6.2 BioLegend Description and Business Overview
6.6.3 BioLegend CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BioLegend CD115 Antibody Product Portfolio
6.6.5 BioLegend Recent Developments/Updates
6.7 LifeSpan BioSciences
6.7.1 LifeSpan BioSciences Company Information
6.7.2 LifeSpan BioSciences Description and Business Overview
6.7.3 LifeSpan BioSciences CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 LifeSpan BioSciences CD115 Antibody Product Portfolio
6.7.5 LifeSpan BioSciences Recent Developments/Updates
6.8 Bio-Rad
6.8.1 Bio-Rad Company Information
6.8.2 Bio-Rad Description and Business Overview
6.8.3 Bio-Rad CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bio-Rad CD115 Antibody Product Portfolio
6.8.5 Bio-Rad Recent Developments/Updates
6.9 Antigenix America
6.9.1 Antigenix America Company Information
6.9.2 Antigenix America Description and Business Overview
6.9.3 Antigenix America CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Antigenix America CD115 Antibody Product Portfolio
6.9.5 Antigenix America Recent Developments/Updates
6.10 Leinco Technologies
6.10.1 Leinco Technologies Company Information
6.10.2 Leinco Technologies Description and Business Overview
6.10.3 Leinco Technologies CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Leinco Technologies CD115 Antibody Product Portfolio
6.10.5 Leinco Technologies Recent Developments/Updates
6.11 Novus Biologicals
6.11.1 Novus Biologicals Company Information
6.11.2 Novus Biologicals Description and Business Overview
6.11.3 Novus Biologicals CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Novus Biologicals CD115 Antibody Product Portfolio
6.11.5 Novus Biologicals Recent Developments/Updates
6.12 Tonbo Biosciences
6.12.1 Tonbo Biosciences Company Information
6.12.2 Tonbo Biosciences Description and Business Overview
6.12.3 Tonbo Biosciences CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Tonbo Biosciences CD115 Antibody Product Portfolio
6.12.5 Tonbo Biosciences Recent Developments/Updates
6.13 ichorbio
6.13.1 ichorbio Company Information
6.13.2 ichorbio Description and Business Overview
6.13.3 ichorbio CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 ichorbio CD115 Antibody Product Portfolio
6.13.5 ichorbio Recent Developments/Updates
6.14 R&D Systems
6.14.1 R&D Systems Company Information
6.14.2 R&D Systems Description and Business Overview
6.14.3 R&D Systems CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 R&D Systems CD115 Antibody Product Portfolio
6.14.5 R&D Systems Recent Developments/Updates
6.15 AffinityImmuno
6.15.1 AffinityImmuno Company Information
6.15.2 AffinityImmuno Description and Business Overview
6.15.3 AffinityImmuno CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.15.4 AffinityImmuno CD115 Antibody Product Portfolio
6.15.5 AffinityImmuno Recent Developments/Updates
6.16 Proteintech Group
6.16.1 Proteintech Group Company Information
6.16.2 Proteintech Group Description and Business Overview
6.16.3 Proteintech Group CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Proteintech Group CD115 Antibody Product Portfolio
6.16.5 Proteintech Group Recent Developments/Updates
6.17 GeneTex
6.17.1 GeneTex Company Information
6.17.2 GeneTex Description and Business Overview
6.17.3 GeneTex CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.17.4 GeneTex CD115 Antibody Product Portfolio
6.17.5 GeneTex Recent Developments/Updates
6.18 Biobyt
6.18.1 Biobyt Company Information
6.18.2 Biobyt Description and Business Overview
6.18.3 Biobyt CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Biobyt CD115 Antibody Product Portfolio
6.18.5 Biobyt Recent Developments/Updates
6.19 Jingjie PTM BioLab
6.19.1 Jingjie PTM BioLab Company Information
6.19.2 Jingjie PTM BioLab Description and Business Overview
6.19.3 Jingjie PTM BioLab CD115 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Jingjie PTM BioLab CD115 Antibody Product Portfolio
6.19.5 Jingjie PTM BioLab Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CD115 Antibody Industry Chain Analysis
7.2 CD115 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CD115 Antibody Production Mode & Process Analysis
7.4 CD115 Antibody Sales and Marketing
7.4.1 CD115 Antibody Sales Channels
7.4.2 CD115 Antibody Distributors
7.5 CD115 Antibody Customer Analysis
8 CD115 Antibody Market Dynamics
8.1 CD115 Antibody Industry Trends
8.2 CD115 Antibody Market Drivers
8.3 CD115 Antibody Market Challenges
8.4 CD115 Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global CD115 Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global CD115 Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global CD115 Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global CD115 Antibody Sales (ml) of Key Manufacturers (2020-2025)
Table 5. Global CD115 Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global CD115 Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global CD115 Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market CD115 Antibody Average Price (US$/ml) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of CD115 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of CD115 Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CD115 Antibody, Product Type & Application
Table 12. Global Key Manufacturers of CD115 Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CD115 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD115 Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CD115 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global CD115 Antibody Sales by Region (2020-2025) & (ml)
Table 18. Global CD115 Antibody Sales Market Share by Region (2020-2025)
Table 19. Global CD115 Antibody Sales by Region (2026-2031) & (ml)
Table 20. Global CD115 Antibody Sales Market Share by Region (2026-2031)
Table 21. Global CD115 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global CD115 Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global CD115 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global CD115 Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America CD115 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America CD115 Antibody Sales by Country (2020-2025) & (ml)
Table 27. North America CD115 Antibody Sales by Country (2026-2031) & (ml)
Table 28. North America CD115 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America CD115 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe CD115 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe CD115 Antibody Sales by Country (2020-2025) & (ml)
Table 32. Europe CD115 Antibody Sales by Country (2026-2031) & (ml)
Table 33. Europe CD115 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe CD115 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific CD115 Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific CD115 Antibody Sales by Region (2020-2025) & (ml)
Table 37. Asia Pacific CD115 Antibody Sales by Region (2026-2031) & (ml)
Table 38. Asia Pacific CD115 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific CD115 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America CD115 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America CD115 Antibody Sales by Country (2020-2025) & (ml)
Table 42. Latin America CD115 Antibody Sales by Country (2026-2031) & (ml)
Table 43. Latin America CD115 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America CD115 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa CD115 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa CD115 Antibody Sales by Country (2020-2025) & (ml)
Table 47. Middle East and Africa CD115 Antibody Sales by Country (2026-2031) & (ml)
Table 48. Middle East and Africa CD115 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa CD115 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global CD115 Antibody Sales (ml) by Type (2020-2025)
Table 51. Global CD115 Antibody Sales (ml) by Type (2026-2031)
Table 52. Global CD115 Antibody Sales Market Share by Type (2020-2025)
Table 53. Global CD115 Antibody Sales Market Share by Type (2026-2031)
Table 54. Global CD115 Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global CD115 Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global CD115 Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global CD115 Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global CD115 Antibody Price (US$/ml) by Type (2020-2025)
Table 59. Global CD115 Antibody Price (US$/ml) by Type (2026-2031)
Table 60. Global CD115 Antibody Sales (ml) by Application (2020-2025)
Table 61. Global CD115 Antibody Sales (ml) by Application (2026-2031)
Table 62. Global CD115 Antibody Sales Market Share by Application (2020-2025)
Table 63. Global CD115 Antibody Sales Market Share by Application (2026-2031)
Table 64. Global CD115 Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global CD115 Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global CD115 Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global CD115 Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global CD115 Antibody Price (US$/ml) by Application (2020-2025)
Table 69. Global CD115 Antibody Price (US$/ml) by Application (2026-2031)
Table 70. Thermo Fisher Scientific Company Information
Table 71. Thermo Fisher Scientific Description and Business Overview
Table 72. Thermo Fisher Scientific CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 73. Thermo Fisher Scientific CD115 Antibody Product
Table 74. Thermo Fisher Scientific Recent Developments/Updates
Table 75. BosterBio Company Information
Table 76. BosterBio Description and Business Overview
Table 77. BosterBio CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 78. BosterBio CD115 Antibody Product
Table 79. BosterBio Recent Developments/Updates
Table 80. Bioss Company Information
Table 81. Bioss Description and Business Overview
Table 82. Bioss CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 83. Bioss CD115 Antibody Product
Table 84. Bioss Recent Developments/Updates
Table 85. BD Biosciences Company Information
Table 86. BD Biosciences Description and Business Overview
Table 87. BD Biosciences CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 88. BD Biosciences CD115 Antibody Product
Table 89. BD Biosciences Recent Developments/Updates
Table 90. RayBiotech Company Information
Table 91. RayBiotech Description and Business Overview
Table 92. RayBiotech CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 93. RayBiotech CD115 Antibody Product
Table 94. RayBiotech Recent Developments/Updates
Table 95. BioLegend Company Information
Table 96. BioLegend Description and Business Overview
Table 97. BioLegend CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 98. BioLegend CD115 Antibody Product
Table 99. BioLegend Recent Developments/Updates
Table 100. LifeSpan BioSciences Company Information
Table 101. LifeSpan BioSciences Description and Business Overview
Table 102. LifeSpan BioSciences CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 103. LifeSpan BioSciences CD115 Antibody Product
Table 104. LifeSpan BioSciences Recent Developments/Updates
Table 105. Bio-Rad Company Information
Table 106. Bio-Rad Description and Business Overview
Table 107. Bio-Rad CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 108. Bio-Rad CD115 Antibody Product
Table 109. Bio-Rad Recent Developments/Updates
Table 110. Antigenix America Company Information
Table 111. Antigenix America Description and Business Overview
Table 112. Antigenix America CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 113. Antigenix America CD115 Antibody Product
Table 114. Antigenix America Recent Developments/Updates
Table 115. Leinco Technologies Company Information
Table 116. Leinco Technologies Description and Business Overview
Table 117. Leinco Technologies CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 118. Leinco Technologies CD115 Antibody Product
Table 119. Leinco Technologies Recent Developments/Updates
Table 120. Novus Biologicals Company Information
Table 121. Novus Biologicals Description and Business Overview
Table 122. Novus Biologicals CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 123. Novus Biologicals CD115 Antibody Product
Table 124. Novus Biologicals Recent Developments/Updates
Table 125. Tonbo Biosciences Company Information
Table 126. Tonbo Biosciences Description and Business Overview
Table 127. Tonbo Biosciences CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 128. Tonbo Biosciences CD115 Antibody Product
Table 129. Tonbo Biosciences Recent Developments/Updates
Table 130. ichorbio Company Information
Table 131. ichorbio Description and Business Overview
Table 132. ichorbio CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 133. ichorbio CD115 Antibody Product
Table 134. ichorbio Recent Developments/Updates
Table 135. R&D Systems Company Information
Table 136. R&D Systems Description and Business Overview
Table 137. R&D Systems CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 138. R&D Systems CD115 Antibody Product
Table 139. R&D Systems Recent Developments/Updates
Table 140. AffinityImmuno Company Information
Table 141. AffinityImmuno Description and Business Overview
Table 142. AffinityImmuno CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 143. AffinityImmuno CD115 Antibody Product
Table 144. AffinityImmuno Recent Developments/Updates
Table 145. Proteintech Group Company Information
Table 146. Proteintech Group Description and Business Overview
Table 147. Proteintech Group CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 148. Proteintech Group CD115 Antibody Product
Table 149. Proteintech Group Recent Developments/Updates
Table 150. GeneTex Company Information
Table 151. GeneTex Description and Business Overview
Table 152. GeneTex CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 153. GeneTex CD115 Antibody Product
Table 154. GeneTex Recent Developments/Updates
Table 155. Biobyt Company Information
Table 156. Biobyt Description and Business Overview
Table 157. Biobyt CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 158. Biobyt CD115 Antibody Product
Table 159. Biobyt Recent Developments/Updates
Table 160. Jingjie PTM BioLab Company Information
Table 161. Jingjie PTM BioLab Description and Business Overview
Table 162. Jingjie PTM BioLab CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 163. Jingjie PTM BioLab CD115 Antibody Product
Table 164. Jingjie PTM BioLab Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. CD115 Antibody Distributors List
Table 168. CD115 Antibody Customers List
Table 169. CD115 Antibody Market Trends
Table 170. CD115 Antibody Market Drivers
Table 171. CD115 Antibody Market Challenges
Table 172. CD115 Antibody Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of CD115 Antibody
Figure 2. Global CD115 Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CD115 Antibody Market Share by Type: 2024 & 2031
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global CD115 Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global CD115 Antibody Market Share by Application: 2024 & 2031
Figure 8. Immunochemistry (IHC)
Figure 9. Immunofluorescence (IF)
Figure 10. Immunoprecipitation (IP)
Figure 11. Western Blot (WB)
Figure 12. ELISA
Figure 13. Others
Figure 14. Global CD115 Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global CD115 Antibody Market Size (2020-2031) & (US$ Million)
Figure 16. Global CD115 Antibody Sales (2020-2031) & (ml)
Figure 17. Global CD115 Antibody Average Price (US$/ml) & (2020-2031)
Figure 18. CD115 Antibody Report Years Considered
Figure 19. CD115 Antibody Sales Share by Manufacturers in 2024
Figure 20. Global CD115 Antibody Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest CD115 Antibody Players: Market Share by Revenue in CD115 Antibody in 2024
Figure 22. CD115 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global CD115 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America CD115 Antibody Sales Market Share by Country (2020-2031)
Figure 25. North America CD115 Antibody Revenue Market Share by Country (2020-2031)
Figure 26. United States CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe CD115 Antibody Sales Market Share by Country (2020-2031)
Figure 29. Europe CD115 Antibody Revenue Market Share by Country (2020-2031)
Figure 30. Germany CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific CD115 Antibody Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific CD115 Antibody Revenue Market Share by Region (2020-2031)
Figure 37. China CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America CD115 Antibody Sales Market Share by Country (2020-2031)
Figure 45. Latin America CD115 Antibody Revenue Market Share by Country (2020-2031)
Figure 46. Mexico CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa CD115 Antibody Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa CD115 Antibody Revenue Market Share by Country (2020-2031)
Figure 51. Turkey CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of CD115 Antibody by Type (2020-2031)
Figure 55. Global Revenue Market Share of CD115 Antibody by Type (2020-2031)
Figure 56. Global CD115 Antibody Price (US$/ml) by Type (2020-2031)
Figure 57. Global Sales Market Share of CD115 Antibody by Application (2020-2031)
Figure 58. Global Revenue Market Share of CD115 Antibody by Application (2020-2031)
Figure 59. Global CD115 Antibody Price (US$/ml) by Application (2020-2031)
Figure 60. CD115 Antibody Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global CD115 Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global CD115 Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global CD115 Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global CD115 Antibody Sales (ml) of Key Manufacturers (2020-2025)
Table 5. Global CD115 Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global CD115 Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global CD115 Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market CD115 Antibody Average Price (US$/ml) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of CD115 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of CD115 Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CD115 Antibody, Product Type & Application
Table 12. Global Key Manufacturers of CD115 Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CD115 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD115 Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CD115 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global CD115 Antibody Sales by Region (2020-2025) & (ml)
Table 18. Global CD115 Antibody Sales Market Share by Region (2020-2025)
Table 19. Global CD115 Antibody Sales by Region (2026-2031) & (ml)
Table 20. Global CD115 Antibody Sales Market Share by Region (2026-2031)
Table 21. Global CD115 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global CD115 Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global CD115 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global CD115 Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America CD115 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America CD115 Antibody Sales by Country (2020-2025) & (ml)
Table 27. North America CD115 Antibody Sales by Country (2026-2031) & (ml)
Table 28. North America CD115 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America CD115 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe CD115 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe CD115 Antibody Sales by Country (2020-2025) & (ml)
Table 32. Europe CD115 Antibody Sales by Country (2026-2031) & (ml)
Table 33. Europe CD115 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe CD115 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific CD115 Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific CD115 Antibody Sales by Region (2020-2025) & (ml)
Table 37. Asia Pacific CD115 Antibody Sales by Region (2026-2031) & (ml)
Table 38. Asia Pacific CD115 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific CD115 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America CD115 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America CD115 Antibody Sales by Country (2020-2025) & (ml)
Table 42. Latin America CD115 Antibody Sales by Country (2026-2031) & (ml)
Table 43. Latin America CD115 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America CD115 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa CD115 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa CD115 Antibody Sales by Country (2020-2025) & (ml)
Table 47. Middle East and Africa CD115 Antibody Sales by Country (2026-2031) & (ml)
Table 48. Middle East and Africa CD115 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa CD115 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global CD115 Antibody Sales (ml) by Type (2020-2025)
Table 51. Global CD115 Antibody Sales (ml) by Type (2026-2031)
Table 52. Global CD115 Antibody Sales Market Share by Type (2020-2025)
Table 53. Global CD115 Antibody Sales Market Share by Type (2026-2031)
Table 54. Global CD115 Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global CD115 Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global CD115 Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global CD115 Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global CD115 Antibody Price (US$/ml) by Type (2020-2025)
Table 59. Global CD115 Antibody Price (US$/ml) by Type (2026-2031)
Table 60. Global CD115 Antibody Sales (ml) by Application (2020-2025)
Table 61. Global CD115 Antibody Sales (ml) by Application (2026-2031)
Table 62. Global CD115 Antibody Sales Market Share by Application (2020-2025)
Table 63. Global CD115 Antibody Sales Market Share by Application (2026-2031)
Table 64. Global CD115 Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global CD115 Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global CD115 Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global CD115 Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global CD115 Antibody Price (US$/ml) by Application (2020-2025)
Table 69. Global CD115 Antibody Price (US$/ml) by Application (2026-2031)
Table 70. Thermo Fisher Scientific Company Information
Table 71. Thermo Fisher Scientific Description and Business Overview
Table 72. Thermo Fisher Scientific CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 73. Thermo Fisher Scientific CD115 Antibody Product
Table 74. Thermo Fisher Scientific Recent Developments/Updates
Table 75. BosterBio Company Information
Table 76. BosterBio Description and Business Overview
Table 77. BosterBio CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 78. BosterBio CD115 Antibody Product
Table 79. BosterBio Recent Developments/Updates
Table 80. Bioss Company Information
Table 81. Bioss Description and Business Overview
Table 82. Bioss CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 83. Bioss CD115 Antibody Product
Table 84. Bioss Recent Developments/Updates
Table 85. BD Biosciences Company Information
Table 86. BD Biosciences Description and Business Overview
Table 87. BD Biosciences CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 88. BD Biosciences CD115 Antibody Product
Table 89. BD Biosciences Recent Developments/Updates
Table 90. RayBiotech Company Information
Table 91. RayBiotech Description and Business Overview
Table 92. RayBiotech CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 93. RayBiotech CD115 Antibody Product
Table 94. RayBiotech Recent Developments/Updates
Table 95. BioLegend Company Information
Table 96. BioLegend Description and Business Overview
Table 97. BioLegend CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 98. BioLegend CD115 Antibody Product
Table 99. BioLegend Recent Developments/Updates
Table 100. LifeSpan BioSciences Company Information
Table 101. LifeSpan BioSciences Description and Business Overview
Table 102. LifeSpan BioSciences CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 103. LifeSpan BioSciences CD115 Antibody Product
Table 104. LifeSpan BioSciences Recent Developments/Updates
Table 105. Bio-Rad Company Information
Table 106. Bio-Rad Description and Business Overview
Table 107. Bio-Rad CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 108. Bio-Rad CD115 Antibody Product
Table 109. Bio-Rad Recent Developments/Updates
Table 110. Antigenix America Company Information
Table 111. Antigenix America Description and Business Overview
Table 112. Antigenix America CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 113. Antigenix America CD115 Antibody Product
Table 114. Antigenix America Recent Developments/Updates
Table 115. Leinco Technologies Company Information
Table 116. Leinco Technologies Description and Business Overview
Table 117. Leinco Technologies CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 118. Leinco Technologies CD115 Antibody Product
Table 119. Leinco Technologies Recent Developments/Updates
Table 120. Novus Biologicals Company Information
Table 121. Novus Biologicals Description and Business Overview
Table 122. Novus Biologicals CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 123. Novus Biologicals CD115 Antibody Product
Table 124. Novus Biologicals Recent Developments/Updates
Table 125. Tonbo Biosciences Company Information
Table 126. Tonbo Biosciences Description and Business Overview
Table 127. Tonbo Biosciences CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 128. Tonbo Biosciences CD115 Antibody Product
Table 129. Tonbo Biosciences Recent Developments/Updates
Table 130. ichorbio Company Information
Table 131. ichorbio Description and Business Overview
Table 132. ichorbio CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 133. ichorbio CD115 Antibody Product
Table 134. ichorbio Recent Developments/Updates
Table 135. R&D Systems Company Information
Table 136. R&D Systems Description and Business Overview
Table 137. R&D Systems CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 138. R&D Systems CD115 Antibody Product
Table 139. R&D Systems Recent Developments/Updates
Table 140. AffinityImmuno Company Information
Table 141. AffinityImmuno Description and Business Overview
Table 142. AffinityImmuno CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 143. AffinityImmuno CD115 Antibody Product
Table 144. AffinityImmuno Recent Developments/Updates
Table 145. Proteintech Group Company Information
Table 146. Proteintech Group Description and Business Overview
Table 147. Proteintech Group CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 148. Proteintech Group CD115 Antibody Product
Table 149. Proteintech Group Recent Developments/Updates
Table 150. GeneTex Company Information
Table 151. GeneTex Description and Business Overview
Table 152. GeneTex CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 153. GeneTex CD115 Antibody Product
Table 154. GeneTex Recent Developments/Updates
Table 155. Biobyt Company Information
Table 156. Biobyt Description and Business Overview
Table 157. Biobyt CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 158. Biobyt CD115 Antibody Product
Table 159. Biobyt Recent Developments/Updates
Table 160. Jingjie PTM BioLab Company Information
Table 161. Jingjie PTM BioLab Description and Business Overview
Table 162. Jingjie PTM BioLab CD115 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 163. Jingjie PTM BioLab CD115 Antibody Product
Table 164. Jingjie PTM BioLab Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. CD115 Antibody Distributors List
Table 168. CD115 Antibody Customers List
Table 169. CD115 Antibody Market Trends
Table 170. CD115 Antibody Market Drivers
Table 171. CD115 Antibody Market Challenges
Table 172. CD115 Antibody Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of CD115 Antibody
Figure 2. Global CD115 Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CD115 Antibody Market Share by Type: 2024 & 2031
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global CD115 Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global CD115 Antibody Market Share by Application: 2024 & 2031
Figure 8. Immunochemistry (IHC)
Figure 9. Immunofluorescence (IF)
Figure 10. Immunoprecipitation (IP)
Figure 11. Western Blot (WB)
Figure 12. ELISA
Figure 13. Others
Figure 14. Global CD115 Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global CD115 Antibody Market Size (2020-2031) & (US$ Million)
Figure 16. Global CD115 Antibody Sales (2020-2031) & (ml)
Figure 17. Global CD115 Antibody Average Price (US$/ml) & (2020-2031)
Figure 18. CD115 Antibody Report Years Considered
Figure 19. CD115 Antibody Sales Share by Manufacturers in 2024
Figure 20. Global CD115 Antibody Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest CD115 Antibody Players: Market Share by Revenue in CD115 Antibody in 2024
Figure 22. CD115 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global CD115 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America CD115 Antibody Sales Market Share by Country (2020-2031)
Figure 25. North America CD115 Antibody Revenue Market Share by Country (2020-2031)
Figure 26. United States CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe CD115 Antibody Sales Market Share by Country (2020-2031)
Figure 29. Europe CD115 Antibody Revenue Market Share by Country (2020-2031)
Figure 30. Germany CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific CD115 Antibody Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific CD115 Antibody Revenue Market Share by Region (2020-2031)
Figure 37. China CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America CD115 Antibody Sales Market Share by Country (2020-2031)
Figure 45. Latin America CD115 Antibody Revenue Market Share by Country (2020-2031)
Figure 46. Mexico CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa CD115 Antibody Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa CD115 Antibody Revenue Market Share by Country (2020-2031)
Figure 51. Turkey CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE CD115 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of CD115 Antibody by Type (2020-2031)
Figure 55. Global Revenue Market Share of CD115 Antibody by Type (2020-2031)
Figure 56. Global CD115 Antibody Price (US$/ml) by Type (2020-2031)
Figure 57. Global Sales Market Share of CD115 Antibody by Application (2020-2031)
Figure 58. Global Revenue Market Share of CD115 Antibody by Application (2020-2031)
Figure 59. Global CD115 Antibody Price (US$/ml) by Application (2020-2031)
Figure 60. CD115 Antibody Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232